Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Fluorotronics’ Carbon-Fluorine Spectroscopy Platform Hailed by Royal Society of Chemistry

Abstract:
Peer reviewed article announces major scientific discovery in nanotechnology; Carbon-Fluorine Spectroscopy can improve and accelerate pharmaceutical and biomedical analyses by detecting, labeling and imaging Carbon-Fluorine (C-F) bonds

Fluorotronics’ Carbon-Fluorine Spectroscopy Platform Hailed by Royal Society of Chemistry

San Diego, CA | Posted on March 31st, 2011

Fluorotronics, Inc., developer of a patented Carbon-Fluorine Spectroscopy platform technology, known as Spectro-Fluor, for molecular detection, measurement and imaging in nanotechnology, pharmaceutical and life science markets, today announced the publication of a ground breaking article: "Development of Carbon-Fluorine Spectroscopy for pharmaceutical and biomedical applications," in the Royal Society of Chemistry's Faraday Discussions[1]. The article was authored by Dr. Bouzid Menaa, Dr. Farid Menaa and Ms. Olga Sharts, distinguished nanotechnology and chemistry experts. Ms. Sharts is also the CEO and founder of Fluorotronics, Inc.



The global organofluorine industry is comprised of diversified markets, including a $1.6 trillion nanotechnology market[2], which produce and use Carbon-Fluorine (C-F) compounds, molecules, products and materials. These C-F materials require extensive analyses during product research, development, and production. Common analytical methods have traditionally involved molecular labeling with radioactive isotopes or fluorescent dyes, which have limited utility, selectivity, sensitivity, stability and often require expensive safety and precautionary measures. In contrast, Fluorotronics' Spectro-Fluor optical technology uses a family of proprietary devices called PLIRFA™ (Pulsed Laser Isochronic Raman and Fluorescence Apparatus) to measure and analyze compounds, molecules, products and materials that contain Carbon-Fluorine (C-F) bonds.



By discovering the characteristic optical signature of Carbon-Fluorine bonds in the fingerprint spectral area of compounds, molecules, products and materials, Fluorotronics' Spectro-Fluor technology delivers the following benefits:



• Identifies and eliminates failed drug candidates at an early stage of drug development

• Provides stable and robust assays, preventing false positive signals from assays

• Enables the ability to study tissues and other biological matters repetitively without losing samples

• Identifies several disease and pharmaceutical targets or bio-markers at the same time (multiplexing)

• Achieves fast results by allowing researchers to obtain data in 0.1 seconds per analysis



"The publication of our research in the Royal Society of Chemistry journal confirms the major impact our Spectro-Fluor optical Carbon-Fluorine Spectroscopy will have on pharmaceutical and biomedical industries," said Olga Sharts, CEO and founder, Fluorotronics. "This article demonstrates that our innovative method and technology will become the ‘gold standard' for pharmaceutical research, development and applications."

####

About Fluorotronics, Inc.
A pioneer in fluoroanalytical nanotechnology, Fluorotronics, Inc. is the first company to introduce and license a patented Carbon-Fluorine Spectroscopy platform technology, known as Spectro-Fluor, for the molecular detection, measurement and imaging of compounds, materials or molecules that contain Carbon-Fluorine (C-F) bonds. This disruptive technology utilizes a family of pulsed laser-based PLIRFA devices to non-invasively detect C-F bonds and taggants across the entire fluoroorganic industry. Fluorotronics provides efficient, integrated and cost-effective solutions that address the product lifecycle in nanotechnology, pharmaceutical and life science markets. For more information about Fluorotronics, please visit www.fluorotronics.com.



About Royal Society of Chemistry

The RSC is the largest organization in Europe for advancing the chemical sciences. Supported by a network of over 46,000 members worldwide and an internationally acclaimed publishing business, its activities span education and training, conferences and science policy, and the promotion of the chemical sciences to the public. RSC was formed in 1980 from the merger of the Chemical Society, the Royal Institute of Chemistry, the Faraday Society and the Society for Analytical Chemistry with a new Royal Charter and the dual role of learned society and professional body.



[1] Development of Carbon-Fluorine Spectroscopy for Pharmaceutical and Biomedical Applications Farid Menaa, Bouzid Menaa, Olga Sharts

Faraday Discuss., 2011, 149, 269

DOI: 10.1039/c005252c



[2] "Nanotechnology Market Forecast to 2013." ResearchandMarkets, 2011 www.researchandmarkets.com/reports/888573/nanotechnology_market_forecast_to_2013.

For more information, please click here

Contacts:
Jessica Anderson
(415) 817-2596

Copyright © Fluorotronics, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Strength in numbers: Researchers develop the first-ever quantum device that detects and corrects its own errors March 4th, 2015

New research could lead to more efficient electrical energy storage March 4th, 2015

Energy-generating cloth could replace batteries in wearable devices March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Chemistry

Chromium-Centered Cycloparaphenylene Rings as New Tools for Making Functionalized Nanocarbons February 24th, 2015

Stretch and relax! -- Losing 1 electron switches magnetism on in dichromium February 23rd, 2015

A straightforward, rapid and continuous method to protect MOF nanocrystals against water February 9th, 2015

Research shows benefits of silicon carbide for sensors in harsh environments: Advantages identified across industries February 9th, 2015

Nanomedicine

Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015

Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015

Announcements

Experiment and theory unite at last in debate over microbial nanowires: New model and experiments settle debate over metallic-like conductivity of microbial nanowires in bacterium March 4th, 2015

Magnetic vortices in nanodisks reveal information: Researchers from Dresden and Jülich use microwaves to read out information from smallest storage devices March 4th, 2015

CiQUS researchers obtain high-quality perovskites over large areas by a chemical method March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Patents/IP/Tech Transfer/Licensing

Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015

onic Present breakthrough in CMOS-based Transceivers for mm-Wave Radar Systems March 1st, 2015

New Paper-like Material Could Boost Electric Vehicle Batteries: Researchers create silicon nanofibers 100 times thinner than human hair for potential applications in batteries for electric cars and personal electronics February 20th, 2015

Nanotech Discoveries Move from Lab to Marketplace with Lintec Deal: Licensing Partnership Brings Together University Technology, New Richardson-Based Facility Directed by Alumni February 9th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE